Cargando…

A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus

The spike (S) protein of SARS coronavirus (SARS-CoV) is responsible for viral binding with ACE2 molecules. Its receptor-binding motif (S-RBM) is located between residues 424 and 494, which folds into 2 anti-parallel β-sheets, β5 and β6. We have previously demonstrated that fragment 450–650 of the S...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jincun, Wang, Wei, Yuan, Zhihong, Jia, Rujing, Zhao, Zhendong, Xu, Xiaojun, Lv, Ping, Zhang, Yan, Jiang, Chengyu, Gao, Xiao-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103343/
https://www.ncbi.nlm.nih.gov/pubmed/17055551
http://dx.doi.org/10.1016/j.virol.2006.09.022
_version_ 1783512038076579840
author Zhao, Jincun
Wang, Wei
Yuan, Zhihong
Jia, Rujing
Zhao, Zhendong
Xu, Xiaojun
Lv, Ping
Zhang, Yan
Jiang, Chengyu
Gao, Xiao-Ming
author_facet Zhao, Jincun
Wang, Wei
Yuan, Zhihong
Jia, Rujing
Zhao, Zhendong
Xu, Xiaojun
Lv, Ping
Zhang, Yan
Jiang, Chengyu
Gao, Xiao-Ming
author_sort Zhao, Jincun
collection PubMed
description The spike (S) protein of SARS coronavirus (SARS-CoV) is responsible for viral binding with ACE2 molecules. Its receptor-binding motif (S-RBM) is located between residues 424 and 494, which folds into 2 anti-parallel β-sheets, β5 and β6. We have previously demonstrated that fragment 450–650 of the S protein (S450–650) is predominantly recognized by convalescent sera of SARS patients. The N-terminal 60 residues (450–510) of the S450–650 fragment covers the entire β6 strand of S-RBM. In the present study, we demonstrate that patient sera predominantly recognized 2 linear epitopes outside the β6 fragment, while the mouse antisera, induced by immunization of BALB/c mice with recombinant S450–650, mainly recognized the β6 strand-containing region. Unlike patient sera, however, the mouse antisera were unable to inhibit the infectivity of S protein-expressing (SARS-CoV-S) pseudovirus. Fusion protein between green fluorescence protein (GFP) and S450–650 (S450–650-GFP) was able to stain Vero E6 cells and deletion of the β6 fragment rendered the fusion product (S511–650-GFP) unable to do so. Similarly, recombinant S450–650, but not S511–650, was able to block the infection of Vero E6 cells by the SARS-CoV-S pseudovirus. Co-precipitation experiments confirmed that S450–650 was able to specifically bind with ACE2 molecules in lysate of Vero E6 cells. However, the ability of S450–510, either alone or in fusion with GFP, to bind with ACE2 was significantly poorer compared with S450–650. Our data suggest a possibility that, although the β6 strand alone is able to bind with ACE2 with relatively high affinity, residues outside the S-RBM could also assist the receptor binding of SARS-CoV-S protein.
format Online
Article
Text
id pubmed-7103343
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71033432020-03-31 A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus Zhao, Jincun Wang, Wei Yuan, Zhihong Jia, Rujing Zhao, Zhendong Xu, Xiaojun Lv, Ping Zhang, Yan Jiang, Chengyu Gao, Xiao-Ming Virology Article The spike (S) protein of SARS coronavirus (SARS-CoV) is responsible for viral binding with ACE2 molecules. Its receptor-binding motif (S-RBM) is located between residues 424 and 494, which folds into 2 anti-parallel β-sheets, β5 and β6. We have previously demonstrated that fragment 450–650 of the S protein (S450–650) is predominantly recognized by convalescent sera of SARS patients. The N-terminal 60 residues (450–510) of the S450–650 fragment covers the entire β6 strand of S-RBM. In the present study, we demonstrate that patient sera predominantly recognized 2 linear epitopes outside the β6 fragment, while the mouse antisera, induced by immunization of BALB/c mice with recombinant S450–650, mainly recognized the β6 strand-containing region. Unlike patient sera, however, the mouse antisera were unable to inhibit the infectivity of S protein-expressing (SARS-CoV-S) pseudovirus. Fusion protein between green fluorescence protein (GFP) and S450–650 (S450–650-GFP) was able to stain Vero E6 cells and deletion of the β6 fragment rendered the fusion product (S511–650-GFP) unable to do so. Similarly, recombinant S450–650, but not S511–650, was able to block the infection of Vero E6 cells by the SARS-CoV-S pseudovirus. Co-precipitation experiments confirmed that S450–650 was able to specifically bind with ACE2 molecules in lysate of Vero E6 cells. However, the ability of S450–510, either alone or in fusion with GFP, to bind with ACE2 was significantly poorer compared with S450–650. Our data suggest a possibility that, although the β6 strand alone is able to bind with ACE2 with relatively high affinity, residues outside the S-RBM could also assist the receptor binding of SARS-CoV-S protein. Elsevier Inc. 2007-03-15 2006-10-20 /pmc/articles/PMC7103343/ /pubmed/17055551 http://dx.doi.org/10.1016/j.virol.2006.09.022 Text en Copyright © 2006 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhao, Jincun
Wang, Wei
Yuan, Zhihong
Jia, Rujing
Zhao, Zhendong
Xu, Xiaojun
Lv, Ping
Zhang, Yan
Jiang, Chengyu
Gao, Xiao-Ming
A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
title A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
title_full A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
title_fullStr A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
title_full_unstemmed A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
title_short A study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of SARS coronavirus
title_sort study on antigenicity and receptor-binding ability of fragment 450–650 of the spike protein of sars coronavirus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103343/
https://www.ncbi.nlm.nih.gov/pubmed/17055551
http://dx.doi.org/10.1016/j.virol.2006.09.022
work_keys_str_mv AT zhaojincun astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT wangwei astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT yuanzhihong astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT jiarujing astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT zhaozhendong astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT xuxiaojun astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT lvping astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT zhangyan astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT jiangchengyu astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT gaoxiaoming astudyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT zhaojincun studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT wangwei studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT yuanzhihong studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT jiarujing studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT zhaozhendong studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT xuxiaojun studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT lvping studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT zhangyan studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT jiangchengyu studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus
AT gaoxiaoming studyonantigenicityandreceptorbindingabilityoffragment450650ofthespikeproteinofsarscoronavirus